Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,328.77
1,099.30
1,152.36
1,007.19
907.85
932.67
756.67
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,328.77
1,099.30
1,152.36
1,007.19
907.85
932.67
756.67
Raw Material Cost
379.93
266.22
224.63
151.65
113.10
100.47
93.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
271.21
221.54
212.90
190.50
146.07
143.15
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.92
3.68
2.86
0.58
0.91
0.17
0.13
Selling and Distribution Expenses
536.55
459.75
550.92
522.41
524.24
620.75
455.37
Other Expenses
-3.33
-0.64
0.14
0.47
0.29
0.87
12.00
Total Expenditure (Excl Depreciation)
1,158.29
944.81
992.73
869.79
787.18
873.24
669.44
Operating Profit (PBDIT) excl Other Income
170.5
154.5
159.60000000000002
137.4
120.7
59.400000000000006
87.2
Other Income
74.90
76.82
87.01
98.08
80.34
59.68
62.61
Operating Profit (PBDIT)
327.51
305.33
304.02
267.37
232.98
144.04
173.97
Interest
3.92
3.68
2.86
0.58
0.91
0.17
0.13
Exceptional Items
14.92
14.57
19.99
13.92
0.92
0.00
-0.07
Gross Profit (PBDT)
948.84
833.08
927.74
855.54
794.75
832.20
662.70
Depreciation
84.51
74.72
59.69
33.79
33.94
27.95
25.43
Profit Before Tax
254.00
241.50
261.46
246.92
199.05
115.91
148.33
Tax
14.35
15.07
15.47
14.49
20.89
7.30
13.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
238.23
226.57
246.52
232.43
178.16
108.61
135.02
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
238.23
226.57
246.52
232.43
178.16
108.61
135.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
238.23
226.57
246.52
232.43
178.16
108.61
135.02
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,697.92
2,603.42
2,444.46
2,291.66
2,095.25
697.44
582.19
Earnings per share (EPS)
1.37
1.28
1.4
1.32
1.01
0.62
0.76
Diluted Earnings per share
1.37
1.28
1.4
1.32
1.01
0.62
0.76
Operating Profit Margin (Excl OI)
12.65%
13.99%
13.65%
13.45%
13.07%
6.05%
11.36%
Gross Profit Margin
25.48%
28.77%
27.87%
27.87%
25.66%
15.42%
22.96%
PAT Margin
17.93%
20.61%
21.39%
23.08%
19.62%
11.65%
17.84%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 20.88% vs -4.61% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 5.12% vs -8.07% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 10.55% vs 5.30% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 5.41% vs 27.59% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
Compare Annual Results Of Chengdu Easton Biopharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,328.77
0
1,328.77
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,328.77
0
1,328.77
Raw Material Cost
379.93
0
379.93
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
271.21
0
271.21
Power Cost
0
0
0.00
Manufacturing Expenses
3.92
0
3.92
Selling and Distribution Expenses
536.55
0
536.55
Other Expenses
-3.33
0.00
-3.33
Total Expenditure (Excl Depreciation)
1,158.29
0
1,158.29
Operating Profit (PBDIT) excl Other Income
170.48
0.00
170.48
Other Income
74.90
0
74.90
Operating Profit (PBDIT)
327.51
0
327.51
Interest
3.92
0
3.92
Exceptional Items
14.92
0
14.92
Gross Profit (PBDT)
948.84
0
948.84
Depreciation
84.51
0
84.51
Profit Before Tax
254.00
0
254.00
Tax
14.35
0
14.35
Provisions and contingencies
0
0
0.00
Profit After Tax
238.23
0
238.23
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
238.23
0
238.23
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
238.23
0
238.23
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,697.92
0
2,697.92
Earnings per share (EPS)
1.37
0
1.37
Diluted Earnings per share
1.37
0
1.37
Operating Profit Margin (Excl OI)
12.65%
0%
0.00
12.65%
Gross Profit Margin
25.48%
0%
0.00
25.48%
PAT Margin
17.93%
0%
0.00
17.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 132.88 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 20.88% vs -4.61% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 23.82 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 5.12% vs -8.07% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.26 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 10.55% vs 5.30% in Dec 2023
Annual - Interest
Interest 0.39 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 5.41% vs 27.59% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.65%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
